SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-06-226787
Filing Date
2006-11-07
Accepted
2006-11-07 16:58:49
Documents
5
Period of Report
2006-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 784507
2 CERTIFICATION OF PEO PURSUANT TO RULE 13A-14(A) OR RULE 15D-14(A) dex311.htm EX-31.1 5762
3 CERTIFICATION OF PFO PURSUANT TO RULE 13A-14(A) OR RULE 15D-14(A) dex312.htm EX-31.2 5823
4 CERTIFICATION BY THE CEO & CFO, AS REQUIRED BY RULE 13A-14(B) OR RULE 15D-14(B) dex321.htm EX-32.1 3402
5 GRAPHIC g23622img001.jpg GRAPHIC 12011
  Complete submission text file 0001193125-06-226787.txt   817680
Mailing Address 34801 CAMPUS DR FREMONT CA 94555
Business Address 34801 CAMPUS DR FREMONT CA 94555 5105741400
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19756 | Film No.: 061194573
SIC: 2836 Biological Products, (No Diagnostic Substances)